Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundAdrenocortical carcinoma (ACC) is an aggressive malignancy with limited therapeutic options, and microRNA (miRNA)-based strategies such as hsa-miR-466 have emerged as potential regulatory interventions.PurposeThis study aimed to investigate the …